Latest News

Global Genitourinary Partnering 2012-2018: Deal trends, players and financials

Tuesday August 14 th 2018

LONDON, August 14, 2018 /PRNewswire/ — Global Genitourinary Partnering 2012 to 2018 provides the full collection of Genitourinary disease deals signed between the world’s pharmaceutical and biotechnology companies since 2012.

Download the full report:

Trends in Genitourinary partnering deals
Financial deal terms for headline, upfront and royalty by stage of development
Genitourinary partnering agreement structure
Genitourinary partnering contract documents
Top Genitourinary deals by value
Most active Genitourinary dealmakers

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor’s product or technology. More often these days these deals tend to be multi-component including both a collaborative RD and a commercialization of outcomes element.

The report takes readers through the comprehensive Genitourinary disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Genitourinary deals.

The report presents financial deal terms values for Genitourinary deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of Genitourinary dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in Genitourinary dealmaking since 2012 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading Genitourinary deals since 2012. Deals are listed by headline value. The chapter includes the top 25 most active Genitourinary dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides comprehensive access to Genitourinary deals since 2012 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all Genitourinary partnering deals by specific Genitourinary target announced since 2012. The chapter is organized by specific Genitourinary therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all Genitourinary partnering deals signed and announced since 2012. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative RD, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Genitourinary partnering and dealmaking since 2012.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Genitourinary technologies and products.

Report scope
Global Genitourinary Partnering 2012 to 2018 is intended to provide the reader with an in-depth understanding and access to Genitourinary trends and structure of deals entered into by leading companies worldwide.

Global Genitourinary Partnering 2012 to 2018 includes:
Trends in Genitourinary dealmaking in the biopharma industry since 2012
Analysis of Genitourinary deal structure
Access to headline, upfront, milestone and royalty data
Access to hundreds of Genitourinary deal contract documents
Comprehensive access to over 3500 Genitourinary deal records
The leading Genitourinary deals by value since 2012
Most active Genitourinary dealmakers since 2012

The report includes deals for the following indications: Discharge, Frequency, Incontinence, Itching, Nocturia, Urgency, Acute kidney injury, Amyloidosis, Chronic kidney disease (CKD), Cystitis, Diabetic nephropathy, Dialysis, Hemolytic-uremic syndrome (HUS), Kidney stones, Nephrotic syndrom, Overactive bladder, Peyronie’s disease, Polycystic kidney disease, Prostate diseases, Prostatitis, Prostate enlargement, Renal failure, Renal infections, Nephritis, Glomerulonephritis, Pyelonephritis, Vesicoureteral reflux, Urinary tract infection (UTI), plus other genitourinary indications.

In Global Genitourinary Partnering 2012 to 2018, available deals and contracts are listed by:
Headline value
Upfront payment value
Royalty rate value
Stage of development at signing
Deal component type
Technology type
Specific therapy indication

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Genitourinary Partnering 2012 to 2018 report provides comprehensive access to available deals and contract documents for over 3500 Genitourinary deals. Analyzing actual contract agreements allows assessment of the following:
• What are the precise Genitourinary rights granted or optioned?
• What is actually granted by the agreement to the partner company?
• What exclusivity is granted?
• What is the payment structure for the deal?
• How aresalesand payments audited?
• What is the deal term?
• How are the key terms of the agreement defined?
• How are IPRs handled and owned?
• Who is responsible for commercialization?
• Who is responsible for development, supply, and manufacture?
• How is confidentiality and publication managed?
• How are disputes to be resolved?
• Under what conditions can the deal be terminated?
• What happens when there is a change of ownership?
• What sublicensing and subcontracting provisions have been agreed?
• Which boilerplate clauses does the company insist upon?
• Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
• Which jurisdiction does the company insist upon for agreement law?

Download the full report:

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at
Tel: +1 (718) 213 4904

Cision View original content:

SOURCE ReportBuyer

DATUM and Zaloni partner to provide customers Data Value from Big Data to Big Enterprise

ANNAPOLIS, Md., Aug. 14, 2018 /PRNewswire/ – DATUM, a leader in data governance, stewardship and metadata management software, today announced a partnership with Zaloni, whose self-service data platform, ZDP, provides industry- leading data lake management and governance capabilities. with the leading solution provider of Data Lakes, Zaloni.  Driven by the vision of creating a metadata catalog that serves both the business users who wants to be able to determine what data they have and where to locate it, and the technical data provider who wants to be able to add new data sets and sources – altogether allowing for an automated way of linking data assets to business definitions and governance rules critical to an enterprise data ecosystem.

DATUM provides data governance and stewardship technology that helps large enterprises chart and navigate their best course to digital leadership.

DATUM provides an Information Governance framework that helps organizations manage enterprise data governance policies. It is purpose-built to discover, understand, connect and measure data value throughout an organization.  Zaloni provides an operational framework for implementing these policies as part of a modern data platform. Together DATUM and Zaloni provide enterprise level data governance from big data to big enterprise and deliver the full Information Value lifecycle for an organization. 

“Our partnership with Zaloni allows us to unify the conversation and reference model between the business subject matter expert, data engineers, and the data science function to achieve meaningful, measurable return from data assets” said Will Crump, DATUM President CEO.

By combining a business-focused metadata management platform with deep functionality in data preparation, the joint offering balances out the full picture of an organization’s need to visualize the connection between business goals and objectives through to the enforcement level of policies, standards and rules. An end-to-end lineage can be traced from the business lineage in data as well as the technical lineage in how data moves through the ecosystem.

“The Zaloni-DATUM partnership was born out of hearing from customers and partners who wanted to be able to better leverage all the hard work that they put into defining their processes, standards, rules, dictionaries and glossaries. Combining DATUM’s Information Value Management platform with the Zaloni Data Platform (ZDP) allows us to deliver the definition around policies that in turn are operationalized in the Zaloni Data Platform,” said Ben Sharma, Zaloni’s CEO.

“I believe the heritage of both our organizations and our practical experiences standing shoulder-to-shoulder with our customers when delivering large enterprise data strategies and Big Data solutions have taught us to listen to the customers and to anticipate their future needs in operating their business,” said DATUM President CEO, Will Crump. “The Zaloni partnership is a natural extension for focus on delivering Data Value for our customers”.

About Zaloni
Zaloni simplifies data management for transformative business insights. We work with pioneering enterprises to modernize their data architecture and operationalize their data lakes to incorporate data into everyday business practices. The Zaloni Data Platform (ZDP) provides total control throughout the data pipeline from ingestion to analytics, with comprehensive data management, governance and self-service data preparation capabilities for IT and business users. A leader in big data for more than a decade, Zaloni’s expertise is deep, spans multiple industries, and has proven invaluable to customers at many of the world’s top companies. We are proud to be recognized by CRN’s 2018 Big Data 100 list, Forbes top 20 big data companies to work for, and Red Herring’s Top 100 North America Award. To learn more, visit

Recognized as a Leader in The Forrester Waveâ„¢: Data Governance, Stewardship and Discovery Providers, and as a Leader in the Gartner Magic Quadrant for Metadata Management Solutions, DATUM drives decision integrity, empowering organizations to discover the right data and make the right decisions faster. By focusing on what data matters and why, DATUM’s proven data governance and stewardship platform, Information Value Management®, delivers business value insights. Today, Fortune 500′s trust DATUM as the data governance system of record to improve operational efficiency, deliver greater analytical insights and simplify compliance and regulatory reporting. To learn more, visit

Media Contacts:
Marie Crump, DATUM LLC

Annie Bishop, Zaloni

Cision View original content with multimedia:


Switch Climbs Off Worst Levels But Remains Firmly Negative

(RTTNews) – Shares of Switch (SWCH) have climbed off their worst levels of the day but remain substantially lower in afternoon trading on Tuesday. After hitting a record intraday low, Switch is currently down by 23 percent.

Switch gapped open sharply lower after the data center operator reported second quarter results that missed expectations and lowered its full-year guidance.

The Relevancy Group releases their new CDP Buyer’s Guide and Issue 18 of The Marketer Quarterly

BOSTON, Aug. 14, 2018 /PRNewswire/ – The Relevancy Group, a leading market research and advisory firm today released “The Relevancy Ring – CDP Buyer’s Guide.”  The research evaluates six CDPs (Customer Data Platforms) that include AgilOne, BlueConic, IgnitionOne, Lytics, RedPoint, and Tealium.  Vendors are evaluated on customer satisfaction and product functionality.

The massive 35-page report also provides details on every aspect of vendor selection and market analysis on marketer trends as well as deep inspection of the platforms evaluated.

“Most marketers today have more customer data than they can effectively leverage for marketing purposes,” says The Relevancy Group Vice President of Research, Nicholas Einstein, “and in many organizations, those data can be found in a wide variety of formats and is spread throughout disparate systems across the enterprise.” “CDPs can help marketers tie these data sources together and make them actionable in real-time,” he continues, “we were extremely impressed by the service and tech we saw from these six top vendors, and forecast continued growth in the space.”

Some of the research findings include:
•Of those marketers that don’t yet have a CDP in place, 32% report planning on implementing one within the next twelve months
•Over 90% of marketers who have a CDP in place report that their marketing KPIs have improved since implementing a CDP
•Over 86% report that their marketing and advertising operations have become more efficient since implementing a CDP

The Relevancy Ring – CDP Buyer’s Guide is available for purchase at $2495.00 and is included in The Research Subscriber Services, that includes 24 reports annually.

The Relevancy Group will be hosting several upcoming webinars to discuss the findings.  You can register for webinars at

An excerpt of the research is also included in issue 18 of The Marketer Quarterly, The Relevancy Group’s digital magazine.  Register to get a free subscription to The Marketer Quarterly online or via the MQ app for any iOS, Android, and Amazon.


Press release distributed by PRLog


Cision View original content:

SOURCE The Relevancy Group, LLC

Gold Reserve Provides Venezuela Update



Gold Reserve Inc. (TSX.V: GRZ) (OTCQX: GDRZF) (“Gold Reserveâ€� or the
“Companyâ€�) is pleased to provide an update on the payments related to
the previously announced Settlement Agreement with Venezuela
(“Settlement Agreementâ€�).

Under the terms of the Settlement Agreement Venezuela agreed to pay Gold
Reserve a total of approximately US $1.032 billion, comprised of
approximately US $792 million in satisfaction of the arbitral ICSID
Award granted in favor of the Company and US $240 million for the sale
of the Company’s technical mining data related to the Siembra Minera
Project. The Company received today Venezuelan government bonds with an
estimated current market value of approximately US$88.5 million as
payment towards the December 2017 and January and February 2018 monthly
installments due under the Settlement Agreement. As a result of this
payment the Company has received an aggregate of US $276 million
(including payments made to the Company’s trust account with Bandes Bank
in Venezuela). Venezuela remains 5 months in arrears (at US $29.5
million per month) on its obligations under the Settlement Agreement.
The Company and Venezuela are continuing discussions to facilitate the
payment of the arrears and future payments.

In addition, approximately US $8 million previously tendered by the
Venezuelan government was transferred recently from the Company’s trust
account in Venezuela to its bank account in North America, leaving
approximately US$37 million remaining in the trust account.

Senior Management of Gold Reserve has been in Caracas working with
Venezuelan officials on matters related to the development of the large
scale Siembra Minera Project. In addition, the Company is also advancing
various social works programs in the project area relating to the
rehabilitation of medical, educational, and recreational facilities
along with engineering work related to landfills, sewage collection,
water distribution systems and related treatment plants to facilitate
the transition of the area to accommodate a nearby major mining
operation. The Company is currently transporting a large sample of the
surface saprolite material to the United States for metallurgical
testing which will aid in the final engineering design of the Early
Works Project.

Doug Belanger, President, stated, “We are very pleased with the receipt
of bonds which confirms our partner’s commitment to meet its obligations
and advance one of the largest undeveloped gold-copper projects in the
world, despite their economic challenges. We look forward to continue
working with Venezuela towards that goal.�

Canaccord Genuity Corp. has been retained by the Company to provide
financial advisory and other services with respect to the bonds.

For further information regarding the Company can be located at,,


This release contains “forward-looking statementsâ€� within the meaning
of applicable U.S. federal securities laws and “forward-looking
information� within the meaning of applicable Canadian provincial and
territorial securities laws and state Gold Reserve’s and its
management’s intentions, hopes, beliefs, expectations or predictions for
the future including without limitation statements with respect to
future payments under the Settlement Agreement, the disposition of the
bonds received by the Company and the development of the Siembra Minera
Project, including social programs to be undertaken in the project area.
Forward-looking statements are necessarily based upon a number of
estimates and assumptions that, while considered reasonable by
management at this time, are inherently subject to significant business,
economic and competitive uncertainties and contingencies.

We caution that such forward-looking statements involve known and
unknown risks, uncertainties and other risks that may cause the actual
outcomes, financial results, performance, or achievements of Gold
Reserve to be materially different from our estimated outcomes, future
results, performance, or achievements expressed or implied by those
forward-looking statements, including without limitation the risks that
payments due under the Settlement Agreement continue to be delayed, the
Company may not receive future payments due under such agreement, the
Company may not be able to repatriate payments that are received, the
bonds described above may not be able to be sold in a timely manner at
their current market value or at all, imposition of further sanctions by
the U.S., Canada or other jurisdictions that may negatively impact our
ability to freely transfer funds from Venezuela or our ability to do
business in Venezuela and the development of the Siembra Minera project
and the activities planned to be undertaken in connection with the
project area may not proceed as anticipated.

This list is not exhaustive of the factors that may affect any of
Gold Reserve’s forward-looking statements. For a more detailed
discussion of the risk factors affecting the Company’s business,
including without limitation the effect of sanctions imposed by the
governments of the United States and Canada against dealings with
certain Venezuelan entities and individuals, see the Company’s Annual
Information Form and Management’s Discussion Analysis for the year
ended December 31, 2017 which have been filed on SEDAR and are available
under the Company’s profile at
and which form part of the Company’s Form 40-F for the year ended
December 31, 2017 which have been filed on EDGAR and are available under
the Company’s profile at

Investors are cautioned not to put undue reliance on forward-looking
statements. All subsequent written and oral forward-looking statements
attributable to Gold Reserve or persons acting on its behalf are
expressly qualified in their entirety by this notice. Gold Reserve
disclaims any intent or obligation to update publicly or otherwise
revise any forward-looking statements or the foregoing list of
assumptions or factors, whether as a result of new information, future
events or otherwise, subject to its disclosure obligations under
applicable rules promulgated by the Securities and Exchange Commission
and applicable Canadian provincial and territorial securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider
(as that term is defined in policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this release.